Seroprevalence of human granulocytic ehrlichiosis among permanent residents of northwestern Wisconsin

Clinical Infectious Diseases

Volumn 27, Issue 6, 1998, Pages 1491-1496

  Bakken, Johan S ^a   Goellner, Paul ^b   Van Etten, Mark ^b   Boyle, Denise Z ^b   Swonger, Oscar L ^b   Mattson, Sandy ^b   Krueth, Jenny ^b   Tilden, Robert L ^b   Asanovich, Kristin ^b   Walls, Jennifer ^b   Dumler, J Stephen ^b  

^a SMDC Health System   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; EHRLICHIOSIS; FEMALE; GEOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCHOOL CHILD; SCREENING TEST; TICK BITE; TREATMENT OUTCOME; UNITED STATES;

EID: 0032466512     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/515048     Document Type: Article

References (28)

1. Bakken JS, Dumler JS, Chen S-M, Eckman MR, VanEtta LL, Walker DH. Human granulocytic ehrlichiosis in the United States: a new species emerging? JAMA 1994; 272:212-8.
2. Dumler JS, Bakken JS. Ehrlichial diseases of humans: emerging tick-borne infections. Clin Infect Dis 1995; 20:1102-10.
3. Aguero-Rosenfeld ME, Horowitz HW, Wormser GP, et al. Human granulocytic ehrlichiosis: a case series from a medical center in New York state. Ann Intern Med 1996; 125:904-8.
4. Bakken JS, Krueth J, Wilson-Nordskog C, et al. Clinical and laboratory characteristics of human granulocytic ehrlichiosis. JAMA 1996; 275: 199-205.
5. Petrovec M, Furlan SL, Zupane TA, et al. Human disease in Europe caused by a granulocytic Ehrlichia species. J Clin Microbiol 1997; 35:1556-9.
6. Sumption KJ, Wright DJM, Cutler SJ, Dale BAS. Human ehrlichiosis in the UK. Lancet 1995; 346:1487-8.
7. Bakken JS, Krueth J, Tilden RL, Dumler JS, Kristiansen BE. Serological evidence of human granulocytic ehrlichiosis in Norway. Eur J Clin Microbiol Infect Dis 1996; 15:829-32.
8. Dumler JS, Dotevall L, Gustafson R, Granstrom M. A population-based seroepidemiologic study of human granulocytic ehrlichiosis and Lyme borreliosis on the west coast of Sweden. J Infect Dis 1997; 175:720-2.
9. Brouqui P, Dumler JS, Lienhard R, Brossard M, Raoult D. Human granulocytic ehrlichiosis in Europe. Lancet 1995; 346:782-3.
10. Dumler JS, Asanovich KM, Bakken JS, Richter P, Kimsey R, Madigan JE. Serologic cross-reactions among Ehrlichia equi, Ehrlichia phagocytophila, and the agent of human granulocytic ehrlichiosis. J Clin Microbiol 1995; 33:1098-103.
11. Chen S-M, Dumler JS, Bakken JS, Walker DH. Identification of a granulocytic Ehrlichia species as the etiologic agent of human disease. J Clin Microbiol 1994; 32:589-95.
12. Edelman DC, Dumler JS. Evaluation of an improved PCR assay for human granulocytic ehrlichiosis. Molecular Diagnosis 1996; 1:41-9.
13. Goodman JL, Nelson C, Vitale B, Madigan JE, Dumler JS, Munderloh UG. Direct cultivation of the causative agent of human granulocytic ehrlichiosis. N Engl J Med 1996; 334:209-15.
14. Wormser G, McKenna D, Aguera-Rosenfeld M, Horowitz H, Munoz J, Nowakowski J. Human granulocytic ehrlichiosis in New York, 1995. MMWR Morb Mortal Wkly Rep 1995; 44:593-5.
15. Pancholi P, Kolbert CP, Mitchell P, et al. Ixodes dammini (scapularis) as a potential vector of human granulocytic ehrlichiosis. J Infect Dis 1995; 172:1007-12.
16. Huycke MM, D'Alessio DD, Marx JJ. Prevalence of antibody to Borrelia burgdorferi by indirect fluorescent antibody assay, ELISA, and western immunoblot in healthy adults in Wisconsin and Arizona. J Infect Dis 1992; 165:1137-47.
17. Smith PF, Benach JL, White DJ, Stroup DF, Morse DL. Occupational risk of Lyme disease in endemic areas of New York state. Ann NY Acad Sci 1988; 539:289-300.
18. Kitron U, Kazmierczak JJ. Spatial analysis of the distribution of Lyme disease in Wisconsin. Am J Epidemiol 1997; 145:658-66.
19. Bakken JS, Krueth J, Tilden RL, Asanovich K, Walls J, Dumler JS. Duration of IFA serologic response in humans infected with the agent of human granulocytic ehrlichiosis (HGE) [abstract no 73]. Clin Infect Dis 1997; 25:368.
20. Centers for Disease Control and Prevention. Lyme disease - United States, 1995. MMWR Morb Mortal Wkly Rep 1995; 45:481-4.
21. Oliver JH, Owsley MR, Hutcheson HJ. Conspecificity of the ticks Ixodes scapularis and Ixodes dammini (Acari: Ixodidae). J Med Entomol 1993; 30:54-63.
22. Standaert SM, Dawson JE, Schaffner W, et al. Ehrlichiosis in a golf-oriented community. N Engl J Med 1995; 333:420-5.
23. Fritz CL, Kjemtrup AM, Conrad PA, et al. Seroepidemiology of emerging tickborne infectious diseases in a northern California community. J Infect Dis 1997; 175:1432-99.
24. Jackson JO, Defoliart GR. Ixodes scapularis Say in northern Wisconsin. J Med Entomol 1970; 7:124-5.
25. Telford SR III, Dawson JE, Katavolos P, Warner CW, Kolbert CP, Persing DH. Perpetuation of the agent of human granulocytic ehrlichiosis (HGE) in a deer tick-rodent cycle. Proc Natl Acad Sci USA 1996; 93: 6209-14.
26. Magnarelli LA, Dumler JS, Anderson JF, Johnson RC, Fikrig E. Coexistence of antibodies to tick-borne pathogens of babesiosis, ehrlichiosis, and Lyme borreliosis in human sera. J Clin Microbiol 1995; 33: 2054-7.
27. Nicholson WL, Childs JE. An indirect immunofluorescence assay using a cell culture-derived antigen for detection of antibodies to the agent of human granulocytic ehrlichiosis. J Clin Microbiol 1997; 35:1510-6.
28. Fingerle V, Goodman JL, Johnson RL, Kurtti TJ, Munderloh UG, Wilske B. Human granulocytic ehrlichiosis in southern Germany: increased seroprevalence in high risk groups. J Clin Microbiol 1997; 35:3244-7.